-
Signature
-
/s/ Christie Cho as attorney-in-fact
-
Issuer symbol
-
RELY
-
Transactions as of
-
25 Nov 2024
-
Net transactions value
-
-$760,783
-
Form type
-
4
-
Filing time
-
27 Nov 2024, 16:15:23 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RELY |
Common Stock |
Options Exercise |
|
+8,977 |
+0.23% |
|
3,882,788 |
25 Nov 2024 |
Direct |
F1, F2 |
| transaction |
RELY |
Common Stock |
Tax liability |
$74,334 |
-3,533 |
-0.09% |
$21.04 |
3,879,255 |
25 Nov 2024 |
Direct |
|
| transaction |
RELY |
Common Stock |
Options Exercise |
|
+27,625 |
+0.71% |
|
3,906,880 |
25 Nov 2024 |
Direct |
F1, F2 |
| transaction |
RELY |
Common Stock |
Tax liability |
$228,726 |
-10,871 |
-0.28% |
$21.04 |
3,896,009 |
25 Nov 2024 |
Direct |
|
| transaction |
RELY |
Common Stock |
Sale |
$457,723 |
-22,198 |
-0.57% |
$20.62 |
3,873,811 |
26 Nov 2024 |
Direct |
F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RELY |
Restricted Stock Units (RSUs) |
Options Exercise |
$0 |
-8,977 |
-50% |
$0.000000 |
8,977 |
25 Nov 2024 |
Common Stock |
8,977 |
|
Direct |
F2, F5 |
| transaction |
RELY |
Restricted Stock Units (RSUs) |
Options Exercise |
$0 |
-27,625 |
-50% |
$0.000000 |
27,625 |
25 Nov 2024 |
Common Stock |
27,625 |
|
Direct |
F2, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: